Bank of New York Mellon’s Aclaris Therapeutics ACRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $306K | Buy |
215,262
+201,689
| +1,486% | +$286K | ﹤0.01% | 3771 |
|
|
2025
Q1 | $20.8K | Buy |
+13,573
| New | +$20.8K | ﹤0.01% | 4068 |
|
|
2024
Q2 | – | Sell |
-232,771
| Closed | -$289K | – | 4115 |
|
|
2024
Q1 | $289K | Sell |
232,771
-49,600
| -18% | -$61.5K | ﹤0.01% | 3783 |
|
|
2023
Q4 | $296K | Buy |
282,371
+39,601
| +16% | +$41.6K | ﹤0.01% | 3799 |
|
|
2023
Q3 | $1.66M | Buy |
242,770
+344
| +0.1% | +$2.36K | ﹤0.01% | 2907 |
|
|
2023
Q2 | $2.51M | Buy |
242,426
+12,156
| +5% | +$126K | ﹤0.01% | 2709 |
|
|
2023
Q1 | $1.86M | Sell |
230,270
-1,343
| -0.6% | -$10.9K | ﹤0.01% | 2842 |
|
|
2022
Q4 | $3.65M | Sell |
231,613
-2,269
| -1% | -$35.7K | ﹤0.01% | 2519 |
|
|
2022
Q3 | $3.68M | Buy |
233,882
+31,683
| +16% | +$499K | ﹤0.01% | 2470 |
|
|
2022
Q2 | $2.82M | Buy |
202,199
+16,603
| +9% | +$232K | ﹤0.01% | 2640 |
|
|
2022
Q1 | $3.2M | Sell |
185,596
-726
| -0.4% | -$12.5K | ﹤0.01% | 2675 |
|
|
2021
Q4 | $2.71M | Buy |
186,322
+4,077
| +2% | +$59.3K | ﹤0.01% | 2804 |
|
|
2021
Q3 | $3.28M | Buy |
182,245
+47,003
| +35% | +$846K | ﹤0.01% | 2713 |
|
|
2021
Q2 | $2.38M | Buy |
135,242
+24,086
| +22% | +$423K | ﹤0.01% | 2879 |
|
|
2021
Q1 | $2.8M | Buy |
111,156
+6,537
| +6% | +$165K | ﹤0.01% | 2728 |
|
|
2020
Q4 | $677K | Sell |
104,619
-4,594
| -4% | -$29.7K | ﹤0.01% | 3465 |
|
|
2020
Q3 | $281K | Hold |
109,213
| – | – | ﹤0.01% | 3742 |
|
|
2020
Q2 | $176K | Sell |
109,213
-108,570
| -50% | -$175K | ﹤0.01% | 3823 |
|
|
2020
Q1 | $227K | Sell |
217,783
-1,996
| -0.9% | -$2.08K | ﹤0.01% | 3697 |
|
|
2019
Q4 | $415K | Buy |
219,779
+95,527
| +77% | +$180K | ﹤0.01% | 3680 |
|
|
2019
Q3 | $134K | Sell |
124,252
-40,957
| -25% | -$44.2K | ﹤0.01% | 3970 |
|
|
2019
Q2 | $362K | Sell |
165,209
-39,621
| -19% | -$86.8K | ﹤0.01% | 3735 |
|
|
2019
Q1 | $1.23M | Buy |
204,830
+6,794
| +3% | +$40.7K | ﹤0.01% | 3037 |
|
|
2018
Q4 | $1.46M | Sell |
198,036
-223,163
| -53% | -$1.65M | ﹤0.01% | 2890 |
|
|
2018
Q3 | $6.12M | Sell |
421,199
-1,802
| -0.4% | -$26.2K | ﹤0.01% | 2302 |
|
|
2018
Q2 | $8.45M | Buy |
423,001
+31,339
| +8% | +$626K | ﹤0.01% | 2110 |
|
|
2018
Q1 | $6.86M | Buy |
391,662
+119,258
| +44% | +$2.09M | ﹤0.01% | 2183 |
|
|
2017
Q4 | $6.72M | Buy |
272,404
+162,389
| +148% | +$4M | ﹤0.01% | 2205 |
|
|
2017
Q3 | $2.84M | Buy |
110,015
+21,754
| +25% | +$561K | ﹤0.01% | 2625 |
|
|
2017
Q2 | $2.39M | Buy |
88,261
+77
| +0.1% | +$2.09K | ﹤0.01% | 2744 |
|
|
2017
Q1 | $2.63M | Sell |
88,184
-26,593
| -23% | -$793K | ﹤0.01% | 2674 |
|
|
2016
Q4 | $3.12M | Buy |
114,777
+68,044
| +146% | +$1.85M | ﹤0.01% | 2589 |
|
|
2016
Q3 | $1.2M | Buy |
46,733
+11,478
| +33% | +$294K | ﹤0.01% | 3072 |
|
|
2016
Q2 | $652K | Buy |
35,255
+19,734
| +127% | +$365K | ﹤0.01% | 3405 |
|
|
2016
Q1 | $294K | Buy |
15,521
+1,238
| +9% | +$23.5K | ﹤0.01% | 3651 |
|
|
2015
Q4 | $385K | Buy |
+14,283
| New | +$385K | ﹤0.01% | 3612 |
|